Cancer of the esophagus

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

The frequency of adenocarcinoma of the esophagus and of the esophagogastric junction continues to rise dramatically in Western countries for reasons that remain unclear. Both of these tumors are strongly associated with segments of intestinal metaplasia in the distal esophagus, some of which may be short and not conspicuous on endoscopic examination. Recent studies suggest that the risk for developing esophageal cancer may be reduced by the regular use of aspirin and, for alcoholics, by abstinence from alcohol. Recently elucidated molecular events that may contribute to esophageal carcinogenesis include overexpression of cyclin D1 and c-erbB-2, altered expression of E-cadherin, and loss of heterozygosity on chromosomes 9p, 9q, and 3p. Evidence continues to accumulate that altered p53 expression is an early and important event in the development of esophageal cancers. Photodynamic therapy appears to be a promising new treatment for esophageal dysplasia and early esophageal cancers. However, enthusiasm for the use of this new therapy must be tempered by the frequency of complications such as esophageal stricture formation and cutaneous photosensitization. Furthermore, meaningful conclusions regarding the frequency with which photodynamic therapy 'cures' dysplasia and early carcinoma will require studies with far longer durations of follow-up than those presently available.

Original languageEnglish (US)
Pages (from-to)392-398
Number of pages7
JournalCurrent Opinion in Gastroenterology
Volume12
Issue number4
StatePublished - 1996

Fingerprint

Esophageal Neoplasms
Photochemotherapy
Alcohol Abstinence
Photosensitivity Disorders
Esophageal Stenosis
Esophagogastric Junction
Loss of Heterozygosity
Cyclin D1
Metaplasia
Cadherins
Alcoholics
Esophagus
Aspirin
Carcinogenesis
Chromosomes
Carcinoma
Skin
Therapeutics
Neoplasms

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Cancer of the esophagus. / Spechler, Stuart Jon.

In: Current Opinion in Gastroenterology, Vol. 12, No. 4, 1996, p. 392-398.

Research output: Contribution to journalArticle

@article{b5b608558aaa40709162e1c6bfbb5fb3,
title = "Cancer of the esophagus",
abstract = "The frequency of adenocarcinoma of the esophagus and of the esophagogastric junction continues to rise dramatically in Western countries for reasons that remain unclear. Both of these tumors are strongly associated with segments of intestinal metaplasia in the distal esophagus, some of which may be short and not conspicuous on endoscopic examination. Recent studies suggest that the risk for developing esophageal cancer may be reduced by the regular use of aspirin and, for alcoholics, by abstinence from alcohol. Recently elucidated molecular events that may contribute to esophageal carcinogenesis include overexpression of cyclin D1 and c-erbB-2, altered expression of E-cadherin, and loss of heterozygosity on chromosomes 9p, 9q, and 3p. Evidence continues to accumulate that altered p53 expression is an early and important event in the development of esophageal cancers. Photodynamic therapy appears to be a promising new treatment for esophageal dysplasia and early esophageal cancers. However, enthusiasm for the use of this new therapy must be tempered by the frequency of complications such as esophageal stricture formation and cutaneous photosensitization. Furthermore, meaningful conclusions regarding the frequency with which photodynamic therapy 'cures' dysplasia and early carcinoma will require studies with far longer durations of follow-up than those presently available.",
author = "Spechler, {Stuart Jon}",
year = "1996",
language = "English (US)",
volume = "12",
pages = "392--398",
journal = "Current Opinion in Gastroenterology",
issn = "0267-1379",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Cancer of the esophagus

AU - Spechler, Stuart Jon

PY - 1996

Y1 - 1996

N2 - The frequency of adenocarcinoma of the esophagus and of the esophagogastric junction continues to rise dramatically in Western countries for reasons that remain unclear. Both of these tumors are strongly associated with segments of intestinal metaplasia in the distal esophagus, some of which may be short and not conspicuous on endoscopic examination. Recent studies suggest that the risk for developing esophageal cancer may be reduced by the regular use of aspirin and, for alcoholics, by abstinence from alcohol. Recently elucidated molecular events that may contribute to esophageal carcinogenesis include overexpression of cyclin D1 and c-erbB-2, altered expression of E-cadherin, and loss of heterozygosity on chromosomes 9p, 9q, and 3p. Evidence continues to accumulate that altered p53 expression is an early and important event in the development of esophageal cancers. Photodynamic therapy appears to be a promising new treatment for esophageal dysplasia and early esophageal cancers. However, enthusiasm for the use of this new therapy must be tempered by the frequency of complications such as esophageal stricture formation and cutaneous photosensitization. Furthermore, meaningful conclusions regarding the frequency with which photodynamic therapy 'cures' dysplasia and early carcinoma will require studies with far longer durations of follow-up than those presently available.

AB - The frequency of adenocarcinoma of the esophagus and of the esophagogastric junction continues to rise dramatically in Western countries for reasons that remain unclear. Both of these tumors are strongly associated with segments of intestinal metaplasia in the distal esophagus, some of which may be short and not conspicuous on endoscopic examination. Recent studies suggest that the risk for developing esophageal cancer may be reduced by the regular use of aspirin and, for alcoholics, by abstinence from alcohol. Recently elucidated molecular events that may contribute to esophageal carcinogenesis include overexpression of cyclin D1 and c-erbB-2, altered expression of E-cadherin, and loss of heterozygosity on chromosomes 9p, 9q, and 3p. Evidence continues to accumulate that altered p53 expression is an early and important event in the development of esophageal cancers. Photodynamic therapy appears to be a promising new treatment for esophageal dysplasia and early esophageal cancers. However, enthusiasm for the use of this new therapy must be tempered by the frequency of complications such as esophageal stricture formation and cutaneous photosensitization. Furthermore, meaningful conclusions regarding the frequency with which photodynamic therapy 'cures' dysplasia and early carcinoma will require studies with far longer durations of follow-up than those presently available.

UR - http://www.scopus.com/inward/record.url?scp=0029840105&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029840105&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0029840105

VL - 12

SP - 392

EP - 398

JO - Current Opinion in Gastroenterology

JF - Current Opinion in Gastroenterology

SN - 0267-1379

IS - 4

ER -